Scleromyositis (scleroderma/polimyositis overlap) is an entity.
Jablonska
S
S
Blaszyk
M
M
D001323:Autoantibodies / Q000032:analysis*; D015415:Biomarkers / Q000032:analysis; D001707:Biopsy, Needle; D002648:Child; D002675:Child, Preschool; D003882:Dermatomyositis / Q000276:immunology* / Q000473:pathology*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D017285:Polymyositis / Q000150:complications / Q000276:immunology / Q000473:pathology; D011379:Prognosis; D018570:Risk Assessment; D012594:Scleroderma, Localized / Q000150:complications / Q000276:immunology / Q000473:pathology; D013577:Syndrome
D001323:Autoantibodies; D015415:Biomarkers